ೖຌૌ৭ക཈ָճɻ୊յ୉ճʤ୉ࡗʥϕϫήϧϞ૓༂Νࢩ͓Ζࡋ๖͹າཔࡋ๖ͶΓΖ΢όϗʖεϥϱએ཮ϧ΢ϓγ΢Φϱηιϱνʖɻ୉ճௗʁঘ‫ݬ‬ɻ༙߄ɻ ҫ༂‫خ‬൭ʀ݊߃ʀӭ཈‫ॶڂݜ‬݆ೖ ໨ ೖ໪ण෉֋ճ͹ࣛɻେනཀྵࣆɻ౽Ҭຬ‫߁ ࢢن‬ౣ୉ָ<RXQJ,QYHVWLJDWRU$ZDUG 2UDOSUHVHQWDWLRQওྯৈଲেԍୌ ޳ಆ൅න࠴ௗ

<,$-XO 7KX ஦ଞ࿪দ ࠅཱི੔үҫྏ‫ڂݜ‬ιϱνʖ ਁҲ‫ ݓ‬দ࿪୉ָϧ΢ϓϙʖϩ

Identification of candidate genes associated with tumorigenicity of cancer
stem cell-like cells in hepatocellular carcinoma cell line Li-7،ࡋ๖‫ࡋؠ‬๖‫ה‬/L͹‫ࡋײؠ‬๖༹ॄ஄Ͷ͕͜Ζଆञ ‫׈‬੓Ͷ‫ؖ‬࿊ͤΖҪఽࢢ͹ಋఈੋࢃိ྆ਤ౽࿪‫װ‬኏ੋ༑ࢃీ෤࢛ౖԲٍҲ࿢஦ଞ߀෋ஞഀ୉ָভԿ‫಼ح‬ՌཀྵԿָ‫ॶڂݜ‬ώ΢ΨϨλʖη‫ڂݜ‬ιϱνʖࡋ๖ࡒྋ֋൅࣪͚ͯͻྡজҫָ‫֋ڂݜ‬൅‫ߑؽ‬<,$High expression of FOXM1 critical for sustaining cell proliferation in
mitochondrial DNA-less liver cancer cellsϝφαϱχϨΠ'1$‫ݰ‬ঙ،ࡋ๖‫Ͳؠ‬ң࣍͠ΗΖࡋ๖ଁ৫ϟΩωθϞ͹մ໎ೖ฽୉ోਁҲ‫੶ݓ‬ઔชദࣴব࣯ࢢদ࿪୉ָ༂ָ෨‫ેخ‬༂ָߪ࠴ञ ࡋ๖ਫ਼෼ָ෨໵দ࿪୉ָ‫ڠ‬ಋ‫ࢬڂݜ‬અҪఽࢢૌ‫࣪ݩࣰ͓׷‬<,$Development of human iPS cell-derived brain endothelial cells for drugtransport studies༂෼ಊସ඲Ճ‫΃ܧ‬͹Ԣ༽Ν໪ࢨͪ͢ϐφL36ࡋ๖༟པ೶݄؇಼ൿࡋ๖͹ࡠ੣ࢃ޳๐ࢢ௃߷ԑ੤ౣඔຽߒઔ୼್݊
ҫ༂݊ӭ‫ࡗݜ‬୉Ӆ༂<,$Elucidation of immune control and symbiotic mechanism by Peyer's patches
resident commensal bacteria using in vitro dendritic cells,QYLWUR धয়ࡋ๖Ν‫ͪ͢༽׈‬Ϗ΢Φϩ൚ૌ৭಼‫ڠ‬ਫ਼ۗͶΓΖ໖Ӻ੏‫ڠͳޜ‬ਫ਼ϟΩωθϞ͹մ໎ࡋ‫࢚ߌݡ‬Ծࢃಲ࢛ࣴీ಺೴ࢢ஝ࢃॡࢢ਄ੋߔҲੜ໼޼ᅵᖔ९ҫ༂‫خ‬൭ʀ݊߃ʀӭ཈‫ॶڂݜ‬୉ࡗ୉ָ૥Ҷీ୉ָ౨‫ښ‬୉ָਈ‫ރ‬୉ָ‫ ܞٵ‬෾

16

6\PSRVLXP

εϱϛζΤϞ̏૓༂‫ڂݜ‬Ͷචགྷ͵‫ؽ‬೵੓ࡋ๖͹֋൅Ԣ༽-XO 7KX ϧ΢ϓϙʖϩ࠴ௗ6છߵ‫౐ښ ܆‬୉ָL36ࡋ๖‫༺ྜྷ ॶڂݜ‬ฑ ཀྵԿָ‫ॶڂݜ‬Induction of dopaminergic neurons from pluripotent stem cells and its
applicationଡ೵੓‫ࡋײ‬๖͖Δ͹χϏϝϱਈ‫ܨ‬෾Կ༢಍ͳͨ͹Ԣ༽ਁሚඊ௙ਈ‫ཱིࢤރ‬ҫྏιϱνʖ஦ԟࢤ຿බӅ࠸ਫ਼ҫྏ‫ڂݜ‬෨

6



Muscular disease modeling by iPS cell-derived skeletal muscle cells
differentiated enough mature to recapitulate pathological condition
L36ࡋ๖͖Δ͹੔ज़ࠐ֪‫ࡋ۔‬๖༢಍ͳ࣮‫΃ڂݜ׳‬͹Ԣ༽ᓐҬӵय़಼ଞஒ໷‫౐ښ‬୉ָL36ࡋ๖‫ॶڂݜ‬7&L5$‫ڠ‬ಋ‫ڂݜ‬ϕϫήϧϞ

6



Development of organs-on-a-chips for pharmaceutical research of infectious
diseasesଃ‫ح‬ορϕٗढ़Ν༽͏ͪ‫ؽ‬೵੓ࡋ๖͹֋൅ͳ‫״‬ઝ঳૓༂‫΃ڂݜ‬͹Ԣ༽߶ࢃ࿪༦‫౐ښ‬୉ָL36ࡋ๖‫ॶڂݜ‬$0('&5(676

ecent advances in the functional applications of human intestinal organoids
Mini- ut as a new modality for drug developmentௐ؇‫ؽ‬೵੓඲ՃͶࣁͤΖ৿ͪ͵ϠξϨτΡͳ͢ͱ͹ௐ؇ΨϩΪό΢χ֋൅Ѫ‫ٳ‬௣ӵ‫ݓ‬Ҭ৏Һ௿ీְ
ࠅཱི੔үҫྏ‫ڂݜ‬ιϱνʖ‫ॶڂݜ‬୉ೖຌһࡰ‫ࣞה‬ճऀ߄઴୉ָ/XQFKHRQVHPLQDUϧϱοϥϱιϝψʖ 

࠴ௗ

/6

-XO 7KX ϧ΢ϓϙʖϩঘ‫ ߄༙ݬ‬ҫ༂‫خ‬൭ʀ݊߃ʀӭ཈‫ॶڂݜ‬

Find more realistic cell functions: Introduction of “3D perfusion cultureequipment” and “full spectral flow cytometer” that applied unique technologiesΓΕϨΠϩ͵ࡋ๖͹ಉ͘ΝஎΖʁϤωʖέ͵ٗढ़ΝԢ༽ͪ̑͢'ᕴླྀക཈ૹ஖͕Γ;ϓϩηϘέφϧϩϓϫʖγ΢φϟʖν͹়͟ղߒീ໎ඛϭίϱϑʖτρέ‫ࣞה‬ճऀ

1,%,216HPLQRUҫ༂‫خ‬൭‫ݜ‬ιϝψʖʛ૓༂‫ڂݜ‬͹າཔʛ

࠴ௗ

16

-XO 7KX ঘ‫ ߄༙ݬ‬ҫ༂‫خ‬൭ʀ݊߃ʀӭ཈‫ॶڂݜ‬

ѭࡲʀटࢭઈ໎஦ଞ༠ืҫ༂‫خ‬൭ʀ݊߃ʀӭ཈‫ॶڂݜ‬17ϧ΢ϓϙʖϩ

16



Expectation for tissue and cell culture technology in vaccine development andmicrobiome drug discoveryϭέοϱ֋൅ɼϜ΢έϫώ΢ΨʖϞ૓༂Ͷ͕͜Ζૌ৭ʀࡋ๖ക཈ٗढ़΃͹‫غ‬ଶᅵᖔ९
ҫ༂‫خ‬൭ʀ݊߃ʀӭ཈‫ॶڂݜ‬ϭέοϱʀΠζϣώϱφ‫ڂݜ‬ιϱνʖಋϖϩηʀϟυΡΩϩ࿊‫ڂݜܠ‬ιϱνʖ

16



AI platform development at Ar HE$,݊߃ʀҫ༂‫ڂݜ‬ιϱνʖ $U&+(5 Ͷ͕͜Ζ‫خ‬൭ϕϧρφϓΧʖϞߑ஛͹ࢾΊਭ޳‫࢚ݣ‬ҫ༂‫خ‬൭ʀ݊߃ʀӭ཈‫ॶڂݜ‬ɻ$,݊߃ʀҫ༂‫ڂݜ‬ιϱνʖ16

ecent progress in the research of rare and intractable diseasesೋ࣑੓࣮‫྘ڂݜ׳‬ҮͶ͕͜Ζ࠹ۛ͹खΕૌΊ໨ଞ༓ଉҫ༂‫خ‬൭ʀ݊߃ʀӭ཈‫ॶڂݜ‬ೋ࣑੓࣮‫ڂݜ׳‬ʀ֋൅ιϱνʖϨώʖηφϧϱηϪʖεϥψϩ‫ڂݜ‬ϕϫζΥέφ.$*$0,ϕϫζΥέφೋ࣑੓࣮‫֋ڂݜ׳‬൅ʀࢩԋ࣪

16



ommitment to drug development in the center for drug design researchDD૓༂υδ΢ϱ‫ڂݜ‬ιϱνʖʤ&''5ʥ͹खΕૌΊ௣ຌߔฑ
ҫ༂‫خ‬൭‫''&ݜ‬5౨୉Ӆ޽ʀώ΢Ψ
6\PSRVLXP

εϱϛζΤϞ‫ ܞٵ‬෾ώ΢Ψώϱέࢾྋ͹‫༽׈‬ͶΓΖ૓༂ఴ֋

-XO 7KX ϧ΢ϓϙʖϩ࠴ௗ

6ฤԮ݊ ԮࢃཀྵՌ୉ָ ஝಼๐େ ஞഀ୉ָ

hallenges in promoting utili ation of biobanks in apanώ΢Ψώϱέཤ‫༽׈‬Ͷ͕͜Ζ՟ୌਁీ ਸध Ҭ৏ ༖ื ‫ ࠞآ‬ཀྵ ਈઔ ๞‫ ٳ‬ઔ໼ ཿଢ࿢ ૖ీ ਇ༟ඔ ঘ‫े ߄༙ ݬ‬ీ೵߄஝಼๐େṦ໼ଞѧ‫ࢢس‬੤‫࢛߁ݬ‬Ԯࢃ୉ָָढ़‫ڂݜ‬ӅϖϩηεητϞ౹߻ՌָָҮԮࢃ୉ָҫָ෨ฯָ݊Ռ‫ٗࠬݗ‬ढ़Ռָ઒ߊ౨‫ښ‬୉ָҫՌָ‫ॶڂݜ‬Ԯࢃ୉ָබӅ৿ҫྏ‫֋ڂݜ‬൅ιϱνʖԮࢃ୉ָָढ़‫ڂݜ‬Ӆҫࣅ༂ָҮ‫ܜ‬ጱٝग़୉ָҫָ෨࣐ծҫՌ୉ָҫָ෨෡଒බӅྡজ‫ڂݜ‬֋൅ιϱνʖҫ༂‫خ‬൭ʀ݊߃ʀӭ཈‫ॶڂݜ‬ക཈ࣁ‫࣪ڂݜݱ‬ஞഀ୉ָ෡଒බӅ͚ͯͻϐφૌ৭ώ΢Ψώϱέιϱνʖ࣐ծҫՌ୉ָ‫׈ڂݜ‬ಊ౹‫ׇ‬ຌ෨ྛཀྵ৻ࠬ࣪

6



iobank network for promotion of utili ation of biobank toward reali ation ofgenomic medicine in apanΰόϞҫྏ͹ࣰ‫ݳ‬Ͷ޴ͪ͜ώ΢Ψώϱέ͹ཤ‫༽׈‬Νଇ਒ͤΖώ΢Ψώϱέʀϋρφϭʖέ͹ߑ஛԰ౣ૓Ҳ౨๼୉ָ߶౵‫ߑؽڂݜ‬າཔ‫ܗ‬ҫྏ૓੔ιϱνʖ౨๼୉ָ౨๼ϟυΡΩϩʀϟΪώϱέ‫ߑؽ‬

186

hanges and degeneration of analytes in biospecimens stored atbiorepositoriesώ΢Ψώϱέࢾྋ͹‫༽׈‬Ͷ͕͜ΖSLWIDOOʁDQDO\WH͹รԿɼร࣯ͳͨ͹ଲԢ‫ٸ‬৕༺ฑਈ಺ઔ‫ཱི͗ݟ‬Ξιϱνʖྡজ‫ॶڂݜ‬‫ ܞٵ‬෾

*HQHUDO3UHVHQWDWLRQҲൢԍୌ࠴ௗ*-XO 7KX ϧ΢ϓϙʖϩ஝ᖔय़໎ ೸‫ۂ‬ʀৱ඾ࢊ‫ٗۂ‬ढ़૱߻‫ࠉ ߑؽڂݜ‬ᖔਚ ࢃཨ୉ָ

Effect of LAS ol on pluripotency and initial trigerm differentiation of human
iPS cellsࡋ๖ఁં஥੓αϧʖΰϱʤ/$6&ROʥ͗ϐφL36ࡋ๖͹າ෾Կ੓͕Γ;ॵ‫غ‬෾Կ๏޴੓Ͷ‫ͤ·ٶ‬Ӫ‫ڻ‬୉ؑ‫࢜ج‬ɼ‫҃ࡖٸ‬೭ɼᅵҬ࠭৭ɼਁຌ߃Ҳɼࠉᖔਚࢃཨ୉ָ୉ָӅҫ޽೸ָ૱߻‫گ‬ү෨ۛ‫ق‬୉ָਫ਼෼ཀྵ޽ָ෨*

Preparation and evaluation of cm-long length stem cell aggregated fiber forpotential use in aneurysm treatmentಊຼᚇ࣑ྏ༽౏Νࢨ޴ͪ͢ௗऊϓΟ΢ώʖয়ࡋ๖‫ॄڿ‬ն͹ࡠ੣ͳ඲Ճᕭ࿍๢ෳౣभҲ࿢ঘચ੥Ԯ໼ζΥ΢Ϟη༺চ‫آ‬ҬྒྷืԮࢃཀྵՌ୉ָ୉ָӅ޽ָ‫ڂݜ‬Ռਫ਼ରҫ޽ָ઒ߊԮࢃཀྵՌ୉ָϓϫϱτΡΠཀྵ޽ָ‫ݜ‬‫ॶڂ‬౨‫ܛ࣌ښ‬ճҫՌ୉ָ࠸ਫ਼ҫྏ‫ڂݜ‬෨౨‫ܛ࣌ښ‬ճҫՌ୉ָ૱߻ҫՌָ‫ڂݜ‬ιϱνʖ

*



Development of intestinal epithelial cell and hepatocyte models stably
expressing multiple drug-metaboli ing en ymes using genome editing
technologyࠞཔ྆ղड़޳ੜߵ߶ࢃ࿪༦౽ీ୐໷

*



ཱིໍ‫ؙ‬୉ָ༂ָ෨‫౐ښ‬୉ָL36ࡋ๖‫ॶڂݜ‬$0('&5(67lastoid derived from primed human pluripotent stem cellsϕϧ΢Ϟ‫ܗ‬ϐφଡ೵੓‫ࡋײ‬๖༟པϔϧηφ΢χࠕଞ૳ชঘ๢࣋ీࢦุ٤ຌߋ‫ّس‬Ҭ‫ݢ‬Ҳ࿢‫౐ښ‬୉ָ߶౵‫ڂݜ‬Ӆ෼࣯ʗࡋ๖౹߻εητϞ‫ ఼ڎ‬:3,L&H06

*



esearch on the generation and evaluation of human-derived cell lines usefulfor alternative reproductive toxicity testing methods for pharmaceuticalsҫ༂඾͹ਫ਼৫ಡ੓ࢾ‫ݩ‬େ଺๑Ͷ༙༽͵ϐφ༟པL36ࡋ๖Ϫϛʖνʖࡋ๖‫ה‬͹ࡠ੣ͳ඲ՃͶ‫ͤؖ‬Ζ‫ڂݜ‬ࢃຌ௜धฑন൥ࢢՅ౽༟ා੤ઔએ‫ࢢܛ‬ԥҬ༓ߵଏཤଢՆ༦ঘౣ഻౽ీҫՌ୉ָ‫ڂݜ‬ਬ਒ຌ෨૱߻ҫՌָ‫ڂݜ‬෨໵ώ΢ΨϨλʖη࣪ࠅཱིҫ༂඾ৱ඾Ӷਫ਼‫҈ॶڂݜ‬સ੓༩଎඲Ճ෨୊್࣪

19

*



oating conditions of culture vessel affect the properties and function ofHepcellsക཈‫ࡒح‬͹αʖφড়݇ͺ+HS*ࡋ๖͹੓࣯ͳ‫ؽ‬೵ΝࠪӊͤΖీ஦ཀྵ‫ࢢܛ‬૮ᖔ࿪ࢢ஦ଞ࿪দ
ࠅཱི੔үҫྏ‫ڂݜ‬ιϱνʖ༂ࡐ࣑ྏ‫ڂݜ‬෨࡝‫ۆ‬୉ָ୉ָӅཀྵ޽ָ‫ڂݜ‬Ռ

<RXQJ,QYHVWLJDWRU$ZDUGV 3RVWHUSUHVHQWDWLRQওྯৈଲেԍୌ ϛηνʖ൅න࠴ௗ<,$-XO 7KX ஦ଞ࿪দ ࠅཱི੔үҫྏ‫ڂݜ‬ιϱνʖ ਁҲ‫ ݓ‬দ࿪୉ָγ΢Φϱηϙʖϩ

Identification of candidate genes associated with tumorigenicity of cancer
stem cell-like cells in hepatocellular carcinoma cell line Li-7،ࡋ๖‫ࡋؠ‬๖‫ה‬/L͹‫ࡋײؠ‬๖༹ॄ஄Ͷ͕͜Ζଆञ ‫׈‬੓Ͷ‫ؖ‬࿊ͤΖҪఽࢢ͹ಋఈੋࢃိ྆ਤ౽࿪‫װ‬኏ੋ༑ࢃీ෤࢛ౖԲٍҲ࿢஦ଞ߀෋
ஞഀ୉ָভԿ‫಼ح‬ՌཀྵԿָ‫ॶڂݜ‬ώ΢ΨϨλʖη‫ڂݜ‬ιϱνʖࡋ๖ࡒྋ֋൅࣪ͯ

͚ͻྡজҫָ‫֋ڂݜ‬൅‫ߑؽ‬<,$

High expression of FOXM1 critical for sustaining cell proliferation in
mitochondrial DNA-less liver cancer cellsϝφαϱχϨΠ'1$‫ݰ‬ঙ،ࡋ๖‫Ͳؠ‬ң࣍͠ΗΖࡋ๖ଁ৫ϟΩωθϞ͹մ໎ೖ฽୉ోਁҲ‫੶ݓ‬ઔชദࣴব࣯ࢢদ࿪୉ָ༂ָ෨‫ેخ‬༂ָߪ࠴ञ ࡋ๖ਫ਼෼ָ෨໵দ࿪୉ָ‫ڠ‬ಋ‫ࢬڂݜ‬અҪఽࢢૌ‫࣪ݩࣰ͓׷‬<,$

Development of human iPS cell-derived brain endothelial cells for drugtransport studies༂෼ಊସ඲Ճ‫΃ܧ‬͹Ԣ༽Ν໪ࢨͪ͢ϐφL36ࡋ๖༟པ೶݄؇಼ൿࡋ๖͹ࡠ੣ࢃ޳๐ࢢ௃߷ԑ੤ౣඔຽߒઔ୼್݊ҫ༂݊ӭ‫ࡗݜ‬୉Ӆ༂<,$

Elucidation of immune control and symbiotic mechanism by Peyer's patches
resident commensal bacteria using in vitro dendritic cells,QYLWUR धয়ࡋ๖Ν‫ͪ͢༽׈‬Ϗ΢Φϩ൚ૌ৭಼‫ڠ‬ਫ਼ۗͶΓΖ໖Ӻ੏‫ڠͳޜ‬ਫ਼ϟΩωθϞ͹մ໎
ࡋ‫࢚ߌݡ‬Ծࢃಲ࢛ࣴీ಺೴ࢢ஝ࢃॡࢢ਄ੋߔҲੜ໼޼ᅵᖔ९
ҫ༂‫خ‬൭ʀ݊߃ʀӭ཈‫ॶڂݜ‬୉ࡗ୉ָ૥Ҷీ୉ָ౨‫ښ‬୉ָਈ‫ރ‬୉ָ

20݆ೖ ۜ ೖ໪ण෉

(QJOLVK3UHVHQWDWLRQ$ZDUG-XO )UL ࠴ௗ(3$ࡗ޳੕ੜ Ԯࢃ୉ָ ౷Ҭ݊෋ ೖຌࣅՌ୉ָϧ΢ϓϙʖϩ

Lysyl oxidase-like is prominent in breast cancer progression through its
en ymatic activities
1L /XK *HGH <RQL .RPDODVDUL 1DKRNR 7RPRQREX )DQ -LDQJ $FRVWD *RQ]DOH]+HULN 5RGULJR <XPD *RKDUD .HQLFKL <DPDPRWR 5LH .LQRVKLWD +LWRVKL 0XUDWD<XVXNH,QRXH0DVDNL\R6DNDJXFKL

2ND\DPD8QLYHUVLW\*XQPD8QLYHUVLW\(3$

EI protein suppresses tumor progression through PD-L1 regulation incancer cells<XPD *RKDUD 1DKRNR 7RPRQREX 5LH .LQRVKLWD +LWRVKL 0XUDWD .HQLFKL<DPDPRWR0DVD\RVKL1DPED1DPKR+XK+LURPL.XPRQ0DVDNL\R

2ND\DPD8QLYHUVLW\1LLPL8QLYHUVLW\(3$

he differentiation otency of human liver organoids towards biliary epithelialcells<DQUDQ7RQJ<XNLNR7REDDQG+LUR\XNL0L]XJXFKL*UDG6FKRI3KDUP6FL2VDND8QLY1,%,2+1275,2VDND8QLY0(,FHQW

2VDND8QLY

(3$Elucidation ofO ID-1 pathophysiology using liver-on-a-chip

6D\DND 'HJXFKL  .DRUL .RVXJL 5LQD +DVKLPRWR $\DND 6DNDPRWR 0DVDNL<DPDPRWR 5\RVXNH 1HJRUR 7DNHVKL 1RGD 7DNX\D <DPDPRWR <XVXNH
7RULVDZD0LNL1DJDR.D]XR7DND\DPD
&HQWHUIRUL36&HOO5HVHDUFKDQG$SSOLFDWLRQ &L5$ .\RWR8QLYHUVLW\*UDGXDWH

6FKRRORI0HGLFLQH.\RWR8QLYHUVLW\&ROOHJHRI3KDUPDFHXWLFDO6FLHQFHV5LWVXPHLNDQ8QLYHUVLW\,QVWLWXWHIRU)URQWLHU/LIHDQG0HGLFDO6FLHQFHV.\RWR
8QLYHUVLW\-67&5(67,QVWLWXWHIRUWKH$GYDQFHG6WXG\RI+XPDQ%LRORJ\ :3,$6+%L .\RWR8QLYHUVLW\0HGLFDOULVN$YRLGDQFHEDVHGRQL36&HOOV7HDP5,.(1&HQWHUIRU$GYDQFHG,QWHOOLJHQFH3URMHFW $,3 'HSDUWPHQWRI0LFUR(QJLQHHULQJ.\RWR8QLYHUVLW\$0('&5(67(3$omparison of culture media for human enteroids from the viewpoint ofpharmacokinetic studies-XPSHL <RNRWD 7RPRNL <DPDVKLWD 7DWVX\D ,QXL :DWDUX .LVKLPRWR +LURVKL
1DNDVH+LUR\XNL0L]XJXFKL
*UDG6FKRI3KDUP6FL2VDND8QLY1DWO,QVWRI%LRPHG,QQRY+HDOWKDQG

1XWULWLRQ1LSSRQ%RHKULQJHU,QJHOKHLP&R/WG6DSSRUR0HG8QLY,QVWIRU
2SHQDQG7UDQVGLVFLSOLQDU\5HV,QLWLDWLYHV2VDND8QLY*OREDO&WUIRU0HG(QJ
DQG,QIRUPDWLFV2VDND8QLY

21(3$

Establishment of hepatocyte organoids using human iPS cell-derived
hepatocytes and their investigation for drug discovery research-XPSHL,QXL<XNLNR7REDDQG+LUR\XNL0L]XJXFKL
*UDG6FKRI3KDUP6FL2VDND8QLY1DWO,QVWRI%LRPHG,QQRY+HDOWKDQG

1XWULWLRQ*OREDO&WUIRU0HG(QJDQG,QIRUPDWLFV2VDND8QLY,QVWIRU2SHQDQG
7UDQVGLVFLSOLQDU\5HV,QLWLDWLYHV2VDND8QLY‫ ܞٵ‬෾

*HQHUDO3UHVHQWDWLRQҲൢԍୌ࠴ௗ*-XO )UL ϧ΢ϓϙʖϩࢃຌ௜ध ౽ీҫՌ୉ָ

Assessment of heterogeneous cell populations in cell lines by Sanalysisࡋ๖‫ה‬Νߑ੔ͤΖࡋ๖ॄ஄͹෈‫ۋ‬Ҳ੓ʛ675ϕϫϓΟ΢ϩ͹෾ੵͳմएʛෳౣ੥‫־‬Ҭชਫ਼஦ଞ߀෋ཀྵԿָ‫ॶڂݜ‬ώ΢ΨϨλʖη‫ڂݜ‬ιϱνʖࡋ๖ࡒྋ֋൅࣪*

uality control of human tissue samples and efforts toward activating clinicalstudy at sukuba Human issue iobank enter͚ͯͻϐφૌ৭ώ΢ΨώϱέιϱνʖͶ͕͜Ζฯଚࢾྋ͹඾࣯؇ཀྵͳྡজ‫ݜ‬‫׈ڂ‬੓ԿΝ໪ࢨͪ͢खΕૌΊ஝಼๐େஞഀ୉ָ෡଒බӅ͚ͯͻϐφૌ৭ώ΢Ψώϱέιϱνʖ*

Anti-aging efficacy of plant extract in dermal senescent cell modelਇൿࡋ๖࿟ԿϠυϩͶ͕͜Ζ৪෼ΦΫη͹߇࿟Կࡠ༽‫ٸ‬ຌহࢢ઎ࢃ಺௣‫ن‬஦ୖཇղࣴీ‫ࢢي‬ඎ‫ڹ‬ਜ਼ࢦࣁਫ਼ಌήϫʖώϩ΢όϗʖεϥϱιϱνʖ*

Development of devices for non-free ing transport of cells and culture models
Aiming to improve between-laboratory reproducibility of experiments usingcells in cultureࡋ๖͕Γ;ക཈ϠυϩΝඉ౜݃༎ૻͤΖυώ΢η͹֋൅ʁക཈ࡋ๖Ν༽͏ࣰͪ‫ݩ‬͹ࢬઅؔ࠸‫ݳ‬੓͹޴৏Ν໪ࢨ͢ͱʄ஝ᖔय़໎
೸‫ۂ‬ʀৱ඾ࢊ‫ٗۂ‬ढ़૱߻‫ߑؽڂݜ‬ਫ਼෼‫ؽ‬೵ཤ༽‫ڂݜ‬෨໵‫ ܞٵ‬෾

3RVWHU6HVVLRQ-XO )  ϛηνʖ൅න3γ΢ΦϱηϙʖϩElucidation of dormancy maintenance mechanism of cancer stem cells using
an in vitro model,QYLWUR ඲Ճ‫ܧ‬Ν༽͏ͪ͗Ξ‫ࡋײ‬๖͹‫ٵ‬ເң࣍‫ߑؽ‬͹մ໎ࠄ‫࢛ڭ‬࿢౤ຌ‫ݨ‬ࢃཇঘ໼ీࢤཱིࢃ޳౨‫ښ‬ཀྵՌ୉ָʀ༂ָ෨ʀ࠸ਫ਼ҫྏָ෾໼

22

3



echnical verification research of cell line authentication method for mousederived cell linesϜΤη༟པࡋ๖‫ה‬͹ࡋ๖೟ৄࢾ‫ݩ‬͹ཱི֮Ν໪ࢨͪ͢‫ݗ‬౾Պଞগ࢞ฑࢃஎࢢ҈౽࣑‫ܛ‬ԚీઇࢢঘᖔΊʹΕ୉୫Ѻঘ‫߄༙ݬ‬ࠅཱི‫֋ڂݜ‬൅๑ਕҫ༂‫خ‬൭ʀ݊߃ʀӭ཈‫ॶڂݜ‬ɻ૓༂ࣁ‫ࢩڂݜݱ‬ԋιϱνʖɻ૓༂ࣁ‫ݱ‬‫ڂݜ‬ϕϫζΥέφʤ-&5%ࡋ๖ώϱέʥ

3



Screening for persistently infected pathogenic viruses in human cell lines
registered at theell ank-&5%ࡋ๖ώϱέͶౌ࿧͠Ηͱ͏Ζϐφ༟པࡋ๖‫ה‬Ͷ͕͜Ζ඾࣯‫ͱ͢ͳࠬݗ‬͹࣍କ‫״‬ઝ੓Τ΢ϩηηέϨʖωϱήԚీ ઇࢢ ‫־‬Ҭ ชਫ਼ ోᬓ ݊ ୉୫ Ѻ  ҈౽ ࣑‫ ܛ‬Պଞ গ࢞ ঘᖔ ΊʹΕ ฑࢃஎࢢઔ޳ӵࢢీ໼ஒࢢ‫ࠦߵ࠺ࠦీٸ‬౽‫ݫ‬৶ੜਭଉ෋ঘ‫߄༙ݬ‬ҫ༂‫خ‬൭ʀ݊߃ʀӭ཈‫ॶڂݜ‬ཀྵԿָ‫ॶڂݜ‬౨‫ښ‬ҫՌࣅՌ୉3

Improving mycoplasma test for cultured cells
0LFKL\D1RJXFKL-XQ,QRXH<XNLR1DNDPXUD&HOO(QJLQHHULQJ'LYLVLRQ%LR5HVRXUFH5HVHDUFK&HQWHU5,.(13

Development research of new cell cryopreservation method৿‫ࡋو‬๖౜݃ฯଚ๑͹‫ݗ‬౾ഇ৖‫ࢀݓ‬ঘᖔΊʹΕਁౣ༅೯‫ݬ‬༡ࢢֱઔ߄ߌঘ‫߄༙ݬ‬ҫ༂‫خ‬൭ʀ݊߃ʀӭ཈‫ࣞהॶڂݜ‬ճऀ/,1.6X

3he role of macrophages in anti-S1

A A therapy for inflammatory diseasesԎ঳੓࣮‫׳‬ͶଲͤΖ߇6$$߇ରྏ๑Ͷ͕͜ΖϜέϫϓΟʖζ͹ༀׄ໨Ծ ཀྵ‫ ܛ‬ঘྜྷ ࿪ࢢ ߧ໨ ߅ଢ ࠦ౽ ദ‫ ن‬༓৶ ಺ฯࢢ ଞీ ౵ ࢃຌ ݊Ҳ ‫ڒ‬ೈߔ๝Ԯ৵Ҳࡗ޳੕ੜԮࢃ୉ָָढ़‫ڂݜ‬Ӆҫࣅ༂ָҮࡋ๖ਫ਼෼ָ෾໼Ԯࢃ୉ָָढ़‫ڂݜ‬Ӆҫࣅ༂ָҮࡋ๖Կָ෾໼ Ԯࢃ୉ָָढ़‫ڂݜ‬Ӆҫࣅ༂ָҮ‫حٷݼ‬ʀ೗ધ಼෾ൽ֐Ռָ3

Development and evaluation of biological tissue-derived culture plates ioulture-Plates using In ody issue Architecture technologyਫ਼ର಼ૌ৭‫ܙ‬੔ढ़Ν༽͏ͪਫ਼ରૌ৭༟པക཈‫خ‬൚ʤ%LR&XOWXUH3ODWHʥ͹֋൅ͳ੓೵඲Ճࠦ౽߃࢛࣋ᖔ෤Ҭ৏༦ղ෤ྡྷ೵໎ѶઔҫՌ୉ָ઎਒ҫ޽ָ‫ڂݜ‬ιϱνʖ3

erification of mycoplasma detection sensitivity using MycoStrip M

0\FR6WULS70Ν༽͏ͪϜ΢αϕϧθϜ‫ݗ‬ड़‫ౕ״‬͹‫ৄݗ‬୉୫Ѻਁ‫ݫ‬ઑദഇ৖‫ࢀݓ‬ঘ‫߄༙ݬ‬ࠅཱི‫֋ڂݜ‬൅๑ਕҫ༂‫خ‬൭ʀ݊߃ʀӭ཈‫ॶڂݜ‬૓༂ࣁ‫ڂݜݱ‬ϕϫζΥέφ -&5%ࡋ๖ώϱέ ψΩϧ΢τηέ‫ࣞה‬ճऀ੣඾‫ة‬ժ֋൅෨ΠϕϨίʖεϥϱ֋൅՟&3

Introduction of university-industry collaboration pro ects in Nacalai es ueIncψΩϧ΢τηέ‫ࣞה‬ճऀͶ͕͜Ζ֐෨‫ͳؖؽڂݜ‬͹‫ڠ‬ಋࣆ‫ۂ‬͹়͟ղ٤༽‫ޛ࣑ߠీڰ࣑ݣ‬౽ਇ໻ਁ‫ݫ‬ઑദԮ࡜༓‫ޙ‬Ծؔࢦ࢞ψΩϧ΢τηέ‫ࣞה‬ճऀ23&3

Development of a novel hiPS maintenance medium for basic and drug
discovery research‫͕ڂݜેخ‬Γ;૓༂‫ڂݜ‬ͶಝԿͪ͢৿‫و‬ϐφL36ࡋ๖༽າ෾Կң࣍കஏ͹֋൅٤༽‫ޛ࣑ߠీڰ࣑ݣ‬౽ਇ໻Ԯ࡜༓‫ޙ‬Ծؔࢦ࢞ψΩϧ΢τηέ‫ࣞה‬ճऀ&3

erification of the usefulness of holographic technology in automated cellmeasurement using fluidlab anva o mbH
IOXLGODE5 DQYDMRऀ Ν༽͏ͪࣙಊࡋ๖‫ܯ‬଎Ͷ͕͜ΖϙϫήϧϓΡρέٗढ़͹༙༽੓Ͷ‫ͤؖ‬Ζ‫ৄݗ‬ঘీྙ໷ϭίϱϑʖτρέ‫ࣞה‬ճऀ&3

ell array by ibidi Micropatterned SlidesLELGLऀϜ΢έϫϏνʖϱηϧ΢χΝ༽͏ͪιϩΠϪ΢໾‫ݬ‬ਇ࿢ೖຌζΥϋτΡέη‫ࣞה‬ճऀϜʖίτΡϱήιʖϩηοʖϞ

&3



Development of serum free medium for human lymphocytes݄ੜΝචགྷͳ͢͵͏ϐφϨϱϏ‫༽ځ‬ໃ݄ੜകஏ͹֋൅߶໨బɾ෫ؔॡߵɾ൩ౣ༓໷ɾሥർஏ‫ٳ‬ٝαʖζϱώ΢Ψ‫ࣞה‬ճऀ

&3



Investigation of live transport of human fibroblasts using the cell proliferation
control mediumଁ৫੏‫ޜ‬ക཈ӹΝ༽͏ͪϐφતңլࡋ๖͹ਫ਼ࡋ๖༎ૻ͹‫ݗ‬౾୎ᖔࠦ‫ࢢل‬౽૖९େ౽ຌय़ղਜ਼ీկٍֹ๡໒༓৙୉ൂ࿢
‫ࣞה‬ճऀϔϩϚϱ‫ࣞה‬ճऀϔϩϚϱ࠸ਫ਼ҫՌָ‫ॶڂݜ‬৶य୉ָ઎Ӹ྘Ү༧߻‫ڂݜ‬‫܊‬ώ΢ΨϟυΡΩϩ‫ॶڂݜ‬৶य୉ָҫָ෨ૌ৭൅ਫ਼ָ‫࣪گ‬৶य୉ָດࠒ‫ܗ‬ʀૹ஥‫ܗ‬υώ΢η‫ڠ‬૓αϱλʖεΠϞ 23(5$‫ ܞٵ‬෾

6SHFLDO/HFWXUH-XO )  ಝพߪԍ࠴ௗ

6/ϧ΢ϓϙʖϩ౽Ҭຬ‫߁ ࢢن‬ౣ୉ָ

he future of in vitro testing supporting drug efficacy and safety assessmentsof pharmaceuticalsҫ༂඾౵͹༂ް͕Γ;҈સ੓඲ՃΝࢩ͓ΖLQYLWUR ࢾ‫ݩ‬͹າཔঘౣ഻ࠅཱིҫ༂඾ৱ඾Ӷਫ਼‫ॶڂݜ‬Ҳൢࡔ஄๑ਕৱ඾༂඾҈સιϱνʖ24

/XQFKHRQ6HPLQDU

ϧϱοϥϱιϝψʖ /6

-XO )  ϧ΢ϓϙʖϩD high-throughput imaging analysis of tissue samples using Organ-on-a-chip
2UJDQRQDFKLSΝ༽͏ͪૌ৭γϱϕϩ͹࣏‫ݫ‬ύ΢ηϩʖϕρφ΢ϟʖζϱӋీઔߝ࢚
江尻 洋子（ϠϪΫϣϧʖυώ΢ηζϡϏϱ‫ࣞה‬ճऀ）（MIMETAS Japan株式会社）$QQXDOJHQHUDOPHHWLQJ
૱ճ-XO )  ϧ΢ϓϙʖϩճๅࠄɼӣӨๅࠄɼ৻٠ʀ݀٠͕Γ;ওྯৈ੔੹൅නɼওྯৈद༫͵ʹ-7&$-6%0*-RLQW6HVVLRQೖຌૌ৭ക཈ָճʀೖຌ‫ેخ‬࿟Կָճ‫࠷ڠ‬ιϝψʖ

-XO )  ϧ΢ϓϙʖϩ࠴ௗ౤ຌ‫ࢃ ݨ‬ཇঘ໼ీࢤཱིࢃ޳౨‫ښ‬ཀྵՌ୉ָ ֡ᖔথ ‫౐ښ‬୉ָ-6

टࢭઈ໎

日本組織培養学会 藤井 万紀子 （広島大学）
日本基礎老化学会 石神 昭人（東京都健康長寿医療センター研究所）

-6



Senescence research from historical theory to future clinical applicationࡋ๖࿟Կ‫ڂݜ‬͹գ‫ڊ‬ɼ‫ࡑݳ‬ɼາཔʂϭ΢ηϜϱ͖ΔιόϨεηΉͲۛ౽ↇ࢚ࢀՑ୕‫ހ‬‫౐ښ‬୉ָҫָ෨෡଒බӅ߶ྺंҫྏϤωρφ

-6



Oxidative stress and organ aging regulated by SODs62'V͗੏‫ͤޜ‬Ζ࢐ԿηφϪηͳଃ‫ح‬࿟Կੜਭ޻ඛోว‫࢛ݓ‬ᖄ୫रҲࠅཱིௗथҫྏ‫ڂݜ‬ιϱνʖʀ࿟ԿηφϪηԢ౶‫ڂݜ‬37-6

ecapitulation ofilson s disease y icell deri ed hepatocytesΤΡϩλϱබಝҡదL36༟པ،ࡋ๖Ͳ͹බସ࠸‫ݳ‬ྜྷ༺ฑཀྵԿָ‫ॶڂݜ‬ώ΢ΨϨλʖη‫ڂݜ‬ιϱνʖL36ࡋ๖߶࣏ಝ੓մੵ֋൅οʖϞ-6

he application of tissue culture to the study of neurodevelopmental disorders൅ୣ্֒‫ڂݜ‬Ͷ͕͜Ζૌ৭ക཈ন໨‫ژ‬Ѭஎ‫ݟ‬ҫྏྏү૱߻ιϱνʖ൅ୣ্֒‫ࡋॶڂݜ‬๖බସ‫ڂݜ‬෨‫ ܞٵ‬෾25

7HFKQLFDO6HPLQDUࡋ๖ക཈‫خ‬൭‫گ‬үҗҽճक࠷ࡋ๖ക཈ࢨ಍࢞ߪसճ-XO )  ϧ΢ϓϙʖϩ76

Program for cell culturists and the instructors for cell culturingࡋ๖ക཈‫خ‬൭‫گ‬үҗҽճक࠷ࡋ๖ക཈ࢨ಍࢞ߪसճฤԮ݊છߵ‫܆‬ೖຌૌ৭ക཈ָճࡋ๖ക཈‫خ‬൭‫گ‬үҗҽճถճ͹ࣛɻɻ୉ճௗʁঘ‫ݬ‬ɻ༙߄ɻ ҫ༂‫خ‬൭ʀ݊߃ʀӭ཈‫ॶڂݜ‬ɻɻɻɻɻɻ࣏୉ճௗʁࡗ޳ɻ੕ੜɻ Ԯࢃ୉ָ26